The solution,
light. The future, bright.
The solution, light. The future, bright.
Lightengale® Illuminated Intravenous Tubing (IVT) System
The solution,
light.
The future, bright.
The solution, light. The future, bright.
Lightengale® Illuminated Intravenous Tubing (IVT) System
The solution,
light. The future, bright.
The solution, light. The future, bright.
Lightengale® Illuminated
Intravenous Tubing (IVT) System
Simple Technology
The Lightengale® system's uncomplicated design uses reliable components to integrate with existing IVT systems, making it easy to use.
Reduced Risk
Studies demonstrate that manual IVT tracing incorrectly identifies lines 7.7% of the time.1 Each additional IVT increases the risk of an adverse drug event by 3%.2 Lightengale® is designed to help avoid this type of preventable medical error.
Increased Efficiency
Nurses can take back valuable time and cognitive energy to care for patients and their families instead of worrying about tracing tangled IVT at every bedside.
- Pinkney, S. et al. Multiple Intravenous Infusions Phase 2b: Laboratory Study. Ont Health Technol Assess Ser 14, 1-163 (2014).
- Kane-Gill, S. L., Kirisci, L., Verrico, M. M. & Rothschild, J. M. Analysis of risk factors for adverse drug events in critically ill patients*. Crit Care Med 40, 823-828, doi:10.1097/CCM.0b013e318236f473 (2012).
Meet Lightengale®
A novel device that quickly and accurately identifies IVTs with a light-emitting fiber optic cable attached along the length of the IVT.
✓ Compatible With All Infusion Pumps
✓ Illuminates Single Lines
✓ Seamless Integration with Current Protocols
Meet Lightengale®
A novel device that quickly and accurately identifies IVTs with a light-emitting fiber optic cable attached along the length of the IVT.
✓ Compatible With All Infusion Pumps
✓ Illuminates Single Lines
✓ Seamless Integration with Current Protocols
Meet Lightengale®
A novel device that quickly and accurately identifies IVTs with a light-emitting fiber optic cable attached along the length of the IVT.
✓ Compatible With All Infusion Pumps
✓ Illuminates Single Lines
✓ Seamless Integration with Current Protocols
Simple Technology
The Lightengale® system's uncomplicated design uses reliable components to integrate with existing IVT systems, making it is easy to use.
Reduced Risk
Studies demonstrate that manual IVT tracing incorrectly identifies lines 7.7% of the time. 1 Each additional IVT increases the risk of an adverse drug event by 3%. 2 Lightengale® is designed to help avoid this type of preventable medical error.
Increased Efficiency
Nurses can take back valuable time and cognitive energy to care for patients and their families instead of worrying about tracing tangled IVT at every bedside.
1. Pinkney, S. et al. Multiple Intravenous Infusions Phase 2b: Laboratory Study. Ont Health Technol Assess Ser 14, 1-163 (2014).
2. Kane-Gill, S. L., Kirisci, L., Verrico, M. M. & Rothschild, J. M. Analysis of risk factors for adverse drug events in critically ill patients*. Crit Care Med 40, 823-828, doi:10.1097/CCM.0b013e318236f473 (2012).
The Company Behind the Solution
Patient safety demands a better solution to time consuming, error-prone manual line tracing. As a company, the mission of Lightengale® is to provide an IVT system that is easily distinguishable, reducing risk and increasing efficiency.
Join Us in Illuminating the Way to Safety
Lightengale® improves the process for quickly and accurately identifying IVT in the ICU. Our focus is to reduce the risk of medication errors, especially for the most vulnerable to harm—pediatric and neonatal patients.3
As we complete our regulatory work, we will welcome partners and collaborators to help improve ICU safety. From research and clinical engagement to development and sales support, there are a variety of ways to partner with us as we illuminate the way to a better solution.
Join Us in Illuminating the Way to Safety
Lightengale® improves the process for quickly and accurately identifying IVT in the ICU. Our focus is to reduce the risk of medication errors, especially for the most vulnerable to harm—pediatric and neonatal patients. 3
As we complete our regulatory work, we will welcome partners and collaborators to help improve ICU safety. From research and clinical engagement to development and sales support, there are a variety of ways to partner with us as we illuminate the way to a better solution.
Join Us in Illuminating
the Way to Safety
Lightengale® improves the process for quickly and accurately identifying IVT in the ICU. Our focus is to reduce the risk of medication errors, especially for the most vulnerable to harm—pediatric and neonatal patients. 3
As we complete our regulatory work, we will welcome partners and collaborators to help improve ICU safety. From research and clinical engagement to development and sales support, there are a variety of ways to partner with us as we illuminate the way to a better solution.
Resource Center
Clinical References
Review studies and research-based conclusions on IV drug administration.
Clinical References
Review studies and research-based conclusions on IV drug administration.
